Abstract:This work demonstrates the way to achieve efficient and target specific delivery of a graphene quantum dot (GQD) using hyaluronic acid (HA) (GQD-HA) as a targeting agent. HA has been anchored to a GQD that accepts the fascinating adhesive properties of the catechol moiety, dopamine hydrochloride, conjugated to HA, which was confirmed by X-ray photoelectron spectroscopy. Transmission electron microscopy revealed a particle size of ∼20 nm, and the fluorescence spectra revealed significant fluorescence intensity … Show more
“…As a target-specific drug delivery carrier, HA has been investigated well in the HA receptor-mediated endocytosis because of its polyanionic characteristics and hydrophilicity, 32 and highly efficient targeted delivery to target sites with HA receptors, such as CD44, HARE, and LYVE-1, for various biological functions. 33,34 According to over-mentioned intensive reports, we chose HA as a targeting ligand to synthesize the HA-Bi 2 O 3 NPs as a multifunctional theranostic platform that can afford spatialand temporal-specific CT imaging and enable overcoming cancer radioresistance. This specifically developed tumortargeted probe holds a great promise as a CT imaging CA with better CT imaging quality at reduced CA dosage when compared with the currently available CAs imaged using a clinical CT scanner.…”
The inherent radioresistance and inaccuracy of localization of tumors weaken the clinical implementation effectiveness of radiotherapy. To overcome these limitations, hyaluronic acid-functionalized bismuth oxide nanoparticles (HA-Bi
2
O
3
NPs) were synthesized by one-pot hydrothermal method for target-specific computed tomography (CT) imaging and radiosensitization of tumor. After functionalization with hyaluronic acid, the Bi
2
O
3
NPs possessed favorable solubility in water and excellent biocompatibility and were uptaken specifically by cancer cells overexpressing CD44 receptors. The as-prepared HA-Bi
2
O
3
NPs exhibited high X-ray attenuation efficiency and ideal radiosensitivity via synergizing X-rays to induce cell apoptosis and arrest the cell cycle in a dose-dependent manner in vitro. Remarkably, these properties offered excellent performance in active-targeting CT imaging and enhancement of radiosensitivity for inhibition of tumor growth. These findings demonstrated that HA-Bi
2
O
3
NPs as theranostic agents exhibit great promise for CT imaging-guided radiotherapy in diagnosis and treatment of tumors.
“…As a target-specific drug delivery carrier, HA has been investigated well in the HA receptor-mediated endocytosis because of its polyanionic characteristics and hydrophilicity, 32 and highly efficient targeted delivery to target sites with HA receptors, such as CD44, HARE, and LYVE-1, for various biological functions. 33,34 According to over-mentioned intensive reports, we chose HA as a targeting ligand to synthesize the HA-Bi 2 O 3 NPs as a multifunctional theranostic platform that can afford spatialand temporal-specific CT imaging and enable overcoming cancer radioresistance. This specifically developed tumortargeted probe holds a great promise as a CT imaging CA with better CT imaging quality at reduced CA dosage when compared with the currently available CAs imaged using a clinical CT scanner.…”
The inherent radioresistance and inaccuracy of localization of tumors weaken the clinical implementation effectiveness of radiotherapy. To overcome these limitations, hyaluronic acid-functionalized bismuth oxide nanoparticles (HA-Bi
2
O
3
NPs) were synthesized by one-pot hydrothermal method for target-specific computed tomography (CT) imaging and radiosensitization of tumor. After functionalization with hyaluronic acid, the Bi
2
O
3
NPs possessed favorable solubility in water and excellent biocompatibility and were uptaken specifically by cancer cells overexpressing CD44 receptors. The as-prepared HA-Bi
2
O
3
NPs exhibited high X-ray attenuation efficiency and ideal radiosensitivity via synergizing X-rays to induce cell apoptosis and arrest the cell cycle in a dose-dependent manner in vitro. Remarkably, these properties offered excellent performance in active-targeting CT imaging and enhancement of radiosensitivity for inhibition of tumor growth. These findings demonstrated that HA-Bi
2
O
3
NPs as theranostic agents exhibit great promise for CT imaging-guided radiotherapy in diagnosis and treatment of tumors.
“…3,[12][13][14] Besides the property of CDs, the physical barrier of the diseased tissue is another obstacle that restricted the application in non-invasive imaging, and rear studies have used CDs in biological imaging. [24][25][26][27] Integrin, such as a v b 3 , is overexpressed on many kinds of tumor cells and tumor neovascular cells. Multidrug resistance further restricted distribution of drugs or probes in the tumor cells, resulting poor tumor treatment outcome and low tumor/normal tissue ratio.…”
Fluorescent carbonaceous dots (CDs) have attracted much attention due to their unique properties.However, their application in non-invasive imaging of diseased tissues was restricted by the short excitation/emission wavelength and the poor targeting efficiency of CDs. In this study, CDs were prepared from sucrose and glutamic acid with a particle size of 57.5 nm. An obvious emission could be observed at 600 nm to 700 nm when excited at around 500 nm. This property enabled CDs with a capacity for deep tissue imaging with low background adsorption. RGD, a ligand which could target most tumor and neovasculature cells, was anchored onto CDs after PEGylation. The product, RGD-PEG-CDs could accumulate in MCF-7/ADR xenografts at high intensity, which was 1.65-fold higher than that of PEG-CDs. Furthermore, RGD-PEG-CDs showed good colocalization with neovasculature. Thus, RGD-PEG-CDs could be used for non-invasive MCF-7/ADR tumor imaging. CDs functionalized with other ligands may also be used as a non-invasive probe for many kinds of tumor imaging. Enhanced real-time monitoring of adeno-associated virus trafficking by virus-quantum dot conjugates, ACS Nano, 2011, 5, 3523-3535. 2 J. Li and J. J. Zhu, Quantum dots for uorescent biosensing and bio-imaging applications, Analyst, 2013, 138, 2506-2515. Fig. 9 Distribution of PEG-CDs and RGD-PEG-CDs in tumor slices. neovessels were stained by anti-CD31 antibody. Blue represents nuclei which stained by DAPI and bar represents 100 mm.
“…The FL mechanism of GQDs may be originated from quantum size effect, electron hole recombination, zigzag sites and defect effect (energy traps). Nahain et al developed GQD-hyaluronic acid (GQD-HA) with an average size of 20 nm for efficient CD44 targeted delivery to tumor-bearing balb/c female mice, demonstrating bright FL from the tumor tissue (73). The chemotherapy was achieved by releasing doxorubicin under mildly acidic conditions, which was loaded onto the basal plane of GQDs.…”
Section: Graphene-based Nanomaterials In Bioimagingmentioning
Graphene-based nanomaterials, due to their unique physicochemical properties, versatile surface functionalization, ultra-high surface area, and good biocompatibility, have attracted considerable interest in biomedical applications such as biosensors, drug delivery, bioimaging, theranostics, and so on. In this review, we will summarize the current advances in bioimaging of graphenebased nanomaterials, including graphene, graphene oxide (GO), reduced graphene oxide (rGO), graphene quantum dots (GQDs), and their derivatives. There are two methods to synthesize graphene-based nanomaterials: in situ synthesis and binding method. We will highlight the molecular imaging modalities including optical imaging (fluorescence (FL), two-photon FL, and Raman imaging), PET/SPECT (positron emission tomography/single photon emission computed tomography), MRI (magnetic resonance imaging), PAI (photoacoustic imaging), CT (computed tomography), and multimodal imaging. In the end, we will elaborate on the prospects and challenges of their future bioimaging applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.